News

The bi-axial agitation properties of XRS 20 Bioreactor System accelerate nutrient and metabolite transport in the cellular micro-environment through improved mixing and higher mass transfer. Thus, the cultures

TOBI Podhaler is new non-nebulized formulation and delivery system of tobramycin that is indicated for CF patients with Pseudomonas aeruginosa (Pa) bacteria in the lungs. The first dry

Probuphine is a long-acting, subdermal implant formulation of buprenorphine for the maintenance treatment of adult patients with opioid dependence. Titan Pharmaceuticals executive vice president and chief development officer

The sanction involves the temporary suspension of Takeda’s activities as vice president of the JPMA for the period of six months starting from 21March 2013. In December 2012

The Holding Incubator Green Chemistry, which has invested € 0.5m, will hold 51% of Deinobiotics while Deinove 49%. Deinove CEO Emmanuel Petiot said, "Our priority at DEINOVE is

The legal action, initiated by Dr. Reddy’s in New Jersey, related to certain bioequivalence studies by the former MDS Pharma Services business unit from 1 January 2000 to

The Duke clinical research unit is the early phase unit of the Duke Clinical Research Institute. Benitec chief executive officer Peter French said, "The TT-034 trial marks the

The research will leverage Tokyo Tech’s TSUBAME2.0 supercomputer for the discovery of drugs for patients suffering from dengue fever/dengue hemorrhagic fever. The first step of the collaborative research

The low-volume viscosupplement product was approved as a pain reliever that improves knee joint function in a single injection. Zimmer senior vice president David Nolan said, "Gel-One Hyaluronate